FDA Committed To Advancing Its Regulatory Science Capacity
This article was originally published in The Rose Sheet
Executive Summary
FDA cites "advances in the application of nanotechnology" among scientific "breakthroughs" that are revolutionizing the health-care community's ability to treat disease, making the notion of personalized care a reality and demanding more FDA involvement